301 related articles for article (PubMed ID: 31545926)
21. [Interventional effect of epalrestat on renal interstitial fibrosis in unilateral ureteral obstruction rats and its mechanism].
Gao YX; Tang J; Zhang Q; Jiang LL; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Jan; 35(1):79-84. PubMed ID: 31245958
[TBL] [Abstract][Full Text] [Related]
22. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
23. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
24. Intermedin attenuates renal fibrosis by induction of heme oxygenase-1 in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Su X; Qiao Y; Fan Y; Peng Z
BMC Nephrol; 2017 Jul; 18(1):232. PubMed ID: 28697727
[TBL] [Abstract][Full Text] [Related]
25. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
[TBL] [Abstract][Full Text] [Related]
26. Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis.
Uchida T; Oda T; Matsubara H; Watanabe A; Takechi H; Oshima N; Sakurai Y; Kumagai H
Ren Fail; 2017 Nov; 39(1):340-349. PubMed ID: 28118775
[TBL] [Abstract][Full Text] [Related]
27. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.
Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F450-9. PubMed ID: 21613422
[TBL] [Abstract][Full Text] [Related]
28. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
29. Semaporin3A inhibitor ameliorates renal fibrosis through the regulation of JNK signaling.
Sang Y; Tsuji K; Fukushima K; Takahashi K; Kitamura S; Wada J
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F740-F756. PubMed ID: 34747196
[TBL] [Abstract][Full Text] [Related]
30. Renal asymmetric dimethylarginine inhibits fibrosis.
Wu M; Yuan M; Wang Y; Tan B; Huang D; Wang C; Zou Y; Ye C
FEBS Open Bio; 2020 Oct; 10(10):2003-2009. PubMed ID: 32794631
[TBL] [Abstract][Full Text] [Related]
31. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
32. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
33. Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.
Li S; Mariappan N; Megyesi J; Shank B; Kannan K; Theus S; Price PM; Duffield JS; Portilla D
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F618-27. PubMed ID: 23804447
[TBL] [Abstract][Full Text] [Related]
34. Carnosic acid attenuates unilateral ureteral obstruction-induced kidney fibrosis via inhibition of Akt-mediated Nox4 expression.
Jung KJ; Min KJ; Park JW; Park KM; Kwon TK
Free Radic Biol Med; 2016 Aug; 97():50-57. PubMed ID: 27212017
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction.
Wang L; Lee JY; Kwak JH; He Y; Kim SI; Choi ME
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F508-17. PubMed ID: 18094035
[TBL] [Abstract][Full Text] [Related]
36. C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease.
Liu SH; Wu CT; Huang KH; Wang CC; Guan SS; Chen LP; Chiang CK
Oncotarget; 2016 Apr; 7(16):21900-12. PubMed ID: 26942460
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
38. Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis.
Khan MAH; Nolan B; Stavniichuk A; Merk D; Imig JD
Front Immunol; 2023; 14():1269261. PubMed ID: 38235144
[TBL] [Abstract][Full Text] [Related]
39. Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway.
Lin P; Qiu F; Wu M; Xu L; Huang D; Wang C; Yang X; Ye C
Pharm Biol; 2023 Dec; 61(1):23-29. PubMed ID: 36524761
[TBL] [Abstract][Full Text] [Related]
40. N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.
Shen Y; Miao NJ; Xu JL; Gan XX; Xu D; Zhou L; Xue H; Zhang W; Lu LM
Acta Pharmacol Sin; 2016 May; 37(5):637-44. PubMed ID: 27041464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
